ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2449

Microrna-346 Regulation of Follicular Helper T Cells Is Involved in the Pathogenesis of rheumatoid Arthritis Disease

Xinyi Tang1, Jie Ma2 and Shengjun Wang3, 1Department of Laboratory Medicine, Jiangsu University Affi�liated People’s Hospital, Zhenjiang, China, 2Department of Laboratory Medicine, Jiangsu University Affiliated People’s Hospital, Zhenjiang, China, 3Department of Laboratory Medicine, Jiangsu University Affiliated People’s Hospital, Zhenjiang, China

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: MicroRNA, pathogenesis, T cells and rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Human Etiology and Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose

Follicular helper T (Tfh) cells have been identified as a new subset of effector helper T cells that are essential in regulating the development of antigen-specific B-cell immunity. Tfh differentiation is regulated by specific transcription factor Bcl-6. Several studies have certified the vital role of Tfh cells in the pathogenesis of autoimmune diseases. MicroRNAs (miRNAs) could negatively regulate gene expression post-transcriptionally and participate in the development of autoimmunity. The purpose of this study is to investigate the function of miR-346 in enhancement of Tfh cells during the pathogenesis of RA.

Methods We detected the proportion of Tfh cells, concentration of IL-21, relative expression of Bcl-6 and IL-21 mRNA as well as miR-346 in RA patients and healthy donors. A Luciferase reporter assay was undertaken for directly proves that Bcl-6 is the functional target of miR-346.The level of Bcl-6 protein in Jurkat cells which were transfected with the miR-346 mimics was detected. Percentage of CD4+CXCR5+ T cells in circulating CD4+ Tcells from healthy donor transfected with miR-346 mimics was examined.

Results

 A significantly increased frequency of CD4+CXCR5+ and CD4+CXCR5+ICOShigh circulating Tfh cells was detected in RA patients, compared with that in healthy controls. Frequency of the circulating Tfh cells showed a positive correlation with anti-CCP antibody in plasma from RA Patients. It has reported that Tfh differentiation is regulated by specific transcription factor Bcl-6. IL-21 is derived from activated Tfh cells and could enhance B cells to produce antibodies. In this study, Bcl-6 and IL-21 mRNA expression in CD4+T cells of RA patients was higher than that in control. Also, a higher IL-21 concentration was found in RA Patients.

   A sequence motif of the 3’UTR of Bcl-6 matches with miR-346. And level of miR-346 expression in circulating CD4+T cells from RA patients was significantly downregulated. We found that miR-346 inhibited the luciferase activity of reporters containing the wild-type UTR1 or UTR2 but not that of the reporter with a mutated 3’UTR unable to bind miR-346.

As Bcl-6 is also expressed in Jurkat cells, miR-346 suppressed the expression of Bcl-6 mRNA in a dose-dependent manner. Manipulation of miR-346 in Jurkat cells also regulated the amount of endogenous Bcl-6 protein.

The percentage of CD4+CXCR5+ T cells in miR-346-transfected group was decreased than that in control group. It could certify the negative function of miR-346 in the differentiation of Tfh cells.

Conclusion In summary, we found that miR-346 could regulate Tfh cells differentiation by targeting Bcl-6, and in RA patients, miR-346 expression was downregulated, which correlated with increased proportion of Tfh cells and disease severity. Collectively, our results may facilitate the validation of miR-346 as a new therapeutic target for the treatment of patients with rheumatoid arthritis.


Disclosure:

X. Tang,
None;

J. Ma,
None;

S. Wang,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/microrna-346-regulation-of-follicular-helper-t-cells-is-involved-in-the-pathogenesis-of-rheumatoid-arthritis-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology